File an Onglyza Heart Attack Lawsuit
Persons and family members of persons who have suffered from Onglyza heart failure, heart attack, and heart disease may file Onglyza lawsuits against the pharmaceutical company AstraZeneca. Through no fault of their own and unaware of any potential danger or heart failure risk, hundreds of thousands of American patients are currently taking Onglyza.
Onglyza was approved in 2009, with the understanding that the diabetes drug did not pose risks to patients for heart attack or other cardiac problems. A large randomized study comparing heart failure rates in diabetics taking Onglyza and those not taking the drug revealed in 2013 that Onglyza increases the risk of heart failure.
A 2015 FDA panel recommended that an Onglyza heart attack warning be adopted into the language of the product’s warning label; a 2016 Onglyza FDA warning mandated a new heart failure warning be added to the labels of Onglyza and similar diabetes drugs. AstraZeneca, the company responsible for Onglyza, did not add a heart attack warning to Onglyza until ordered to do so in 2016.
A new diabetes drug used to regulate blood glucose levels, Onglyza has become popular in the United States for its effectiveness and lack of serious side effects. Now doctors and consumers realize Onglyxa poses serious and even fatal risks. Plaintiffs are filing Onglyza lawsuits on the basis of new information regarding the Onglyza heart failure risk.
Onglyza Heart Failure Lawsuits
If you or a loved one has been diagnosed with heart disease from Onglyza or suffered a heart attack, you may qualify to file an Onglyza lawsuit to recover compensation for damages you have suffered. Filing an Onglyza lawsuit serves two purposes:
First, filing a lawsuit can achieve financial compensation for your family for the suffering, damages, lost wages, and medical expenses encountered due to Onglyza heart failure.
Second, Onglyza lawsuits hold AstraZeneca accountable, pushing the pharmaceutical company ensure the safety of its medical products. Onglyza lawsuit claims will likely be tried as Multidistrict Litigation (MDL), which brings similar product liability cases together for greater efficiency and effectiveness while still preserving the unique details of each case. MDL enables individual consumers to advance justice and safeguard others against the danger of Onglyza heart attack or other product dangers in the future.
Our lawyers handling Onglyza lawsuits throughout the U.S. offer free case review with no further obligation. Complete our simple contact form or chat online with our representatives. One of our attorneys handling national pharmaceutical claims will respond promptly. We will be happy to discuss your circumstances in detail and answer your questions as definitively as possible.
Onglyza Lawsuits Are Not Class Action Lawsuits
Onglyza lawsuits will not be class action lawsuits where those filing a claim can expect to receive only very small settlements. Although Onglyza lawsuits will likely become Multi-District Litigation (MDL), each Onglyza lawsuit claim will be handled on its own merit and each plaintiff will receive compensation in accordance with the individual damages they suffered. MDL is a legal procedure that expedites cases that share a common injury among many plaintiffs across the country, while preserving details of individual cases to ensure fair compensation.
Onglyza Lawsuits: No Fees Unless We Collect for You
We will represent all persons involved in an Onglyza lawsuit on a contingency basis, meaning our attorneys never charge any legal fees unless we win compensation in your case. For a free no-obligation consultation please fill out our short online contact form and one of our Onglyza lawyers will contact you to answer any of your questions.
No-Cost, No-Obligation Onglyza Lawsuit Case Review If You or a Loved One Suffered from Onglyza Heart Disease
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.OnderLaw.com or call 1-877-ONDER-LAW.